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Human herpesvirus 8 (HHV-8) has been causally linked to Kaposi’s sarcoma (KS). There is significant homology between
some HHV-8 genes and cellular genes including D-type cyclin (vCYC), G protein coupled receptor (vGCR), macrophage
inflammatory proteins (vMIP-I, vMIP-II), bcl-2 (vBCL2), interferon regulatory factor-1 (vIRF1), interleukin-6 (vIL6), and com-
plement-binding protein (vCBP). In this study, we analyzed expression of these viral homologs and HIV-1 Tat by reverse-
transcriptase polymerase chain reaction (RT-PCR) coupled with Southern blot hybridization in AIDS-KS (AKS) tissue, classic
KS tissue(CKS), and peripheral blood mononuclear cells, and phorbol ester (TPA)-treated and untreated HHV-8 positive
lymphoma cells (BCBL1). While vCYC (AKS 6 of 6; CKS 3 of 3), vMIP-I (AKS 5 of 6, CKS 3 of 3), vBCL2 (AKS 6 of 6; CKS 3 of
3), and vIRF1 (AKS 5 of 6, CKS 3 of 3) transcripts were detected in both AKS and CKS, vGCR and HIV-1 Tat were expressed
only in AKS samples (vGCR: AKS 3 of 6, CKS 0 of 3; Tat: AKS 4 of 6, CKS 0 of 3). vMIPII, vCBP, and vIL6 expression were not
detected in any KS samples. Since vGCR expression is limited to AKS, it is possible that vGCR is activated by HIV-1 Tat. These
results suggest that HIV-1 Tat may contribute to AKS pathogenesis through the tumorigenic and angiogenic effects of vGCR.
© 2000 Academic PressINTRODUCTION
HHV-8 DNA sequences were first described in
AIDS-KS (AKS) tissue (Chang et al., 1994). Subsequently,
many studies have documented HHV-8 DNA in all forms
of KS including AKS, CKS, endemic African KS, and iat-
rogenic KS (Chang et al., 1994; Boshoff et al., 1995; Dupin
et al., 1995; Huang et al., 1995; Moore and Chang, 1995;
Su et al.,1995; Rady et al., 1995, 1998; Cesarman et al.,
1996).
Detailed analysis of the HHV-8 genome has revealed
that certain viral gene products possess significant ho-
mology to cellular genes, some of which have the poten-
tial for growth promotion and immunoregulation. Homol-
ogies include those to D-type cyclins (vCYC), G protein
coupled receptor (vGCR), macrophage inflammatory pro-
teins (vMIP-I and vMIP-II), bcl-2 (vBCL2), interferon reg-
ulatory factor-1 (vIRF1), interleukin-6 (vIL-6), and comple-
ment-binding protein (vCBP) (Cesarman et al., 1996;
Moore et al., 1996; Russo et al., 1996).
Transcription mapping studies with an HHV-8 latently
infected lymphoid cell line (BC1) indicate that viral gene
1 These authors contributed equally to this study.
2 To whom correspondence and reprint requests should be ad-dressed at The University of Texas Medical Branch, Route 1070,
Galveston, TX 77555-1070. Fax: (281) 335-4605.
247expression may be classified as fully constitutive (class
I), as significantly enhanced by tetradecanoylphorbol ac-
etate (TPA) treatment (class II), or as inducible only by
TPA treatment (class III) (Sarid et al.,1998). In KS lesions
and in established HHV-8-positive lymphoid cell lines,
the expressions of these latent and lytic HHV-8 genes
appear to differ (Davis et al., 1997; reviewed in Moore
and Chang, 1998).
HIV-1 Tat has been shown to induce an increase in
HHV-8 viral copy number in BCBL-1 cells as well as
peripheral blood mononuclear cells (PBMC) from AKS
patients, AIDS patients without KS, and HIV-negative
immunosuppressed renal transplant patients without KS
(Harrington et al., 1997). These results strongly suggest
that HIV-1 Tat reactivates latent HHV-8, thus increasing
HHV-8 viral load. We have analyzed the expression of the
HHV-8 cellular homolog genes vGCR, vBCL2, vMIP-I,
vMIP-2, vCYC, vIL-6, vIRF1, vCBP, and the HIV-1 Tat gene
in 6 AKS lesions, 3 CKS lesions, 2 PBMC samples from
patients with CKS, and BCBL-1 cells with and without
TPA induction. In light of the work of Harrington et al.
(1997), we sought to compare the expression of HHV-8
cellular homolog genes in HIV-positive and HIV-negative
KS to identify viral genes, which may be differentially
regulated by HIV-1 Tat in AKS and thus specifically con-
tribute to AKS tumorigenesis.
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248 YEN-MOORE ET AL.RESULTS
xpression of viral cellular homolog genes
nd HIV-1 Tat
Transcription of vBCL2 and vCYC was observed in all
S samples, all PBMC samples from KS patients, and
FIG. 1. HHV-8 cellular homolog and HIV-1 Tat gene expression. Lane
lesion (nodular) from CKS patient B; lane 4: skin lesion (nodular) from
lesion (nodular) from AKS patient D; lane 7: skin lesion from AKS patient
from AKS patient G; lane 10: skin lesion (nodular) from AKS patient
HIV-negative patient without KS; lane 13: normal human microvascula
normal skin from HIV negative patient; lane 16: reagent control (excep
BCBL-1 cells; lane 18: TPA-treated BCBL-1 cells. CP, cyclophilin intern
T
HHV-8 Cellular Homolog a
CKS AKS
1 2 3 4 5 6 7 8
vGCR 2 2 2 2 2 2 2 2
vBCL2 1 1 1 1 1 1 1 1
IRF1 w 2 1 1 1 w 2 1
MIP-I 1 1 1 1 1 1 2 1
MIP-II 2 2 2 2 2 2 2 2
CYC 1 1 1 1 1 1 1 1
IL-6 2 2 2 2 2 2 2 2
CBP 2 2 2 2 2 2 2 2
at 2 2 2 2 2 2 2 1
a This table summarizes the data presented in Fig. 1.
b w, weak positive signal.
c HIV-1 Tat positive control.CBL-1 cells with and without TPA treatment (see Fig. 1
nd Table 1). Expression of vIRF1 was observed in 5 of 6
KS samples, 3 of 3 CKS samples, and 1 of 2 PBMC
amples, and BCBL-1 cells with or without TPA treat-
ent. Transcription of vMIP-II, vIL-6, and vCBP genes
as observed only in TPA-treated BCBL-1 cells. vGCR
C from CKS patient A; lane 2: PBMC from CKS patient B; lane 3: skin
tient C; lane 5: skin lesion (nodular) from CKS patient A; lane 6: skin
8: skin lesion (nodular) from AKS patient F; lane 9: skin lesion (plaque)
e 11: skin lesion (nodular) from AKS patient I; lane 12: PBMC from
helial cells; lane 14: normal human epidermal keratinocytes; lane 15:
IV-1 Tat, lane 16 is HIV-1 Tat positive control); lane 17: TPA-untreated
rol gene.
-1 Tat Gene Expressiona
Controls BCBL-1
10 11 12 13 14 15 16 17 18
1 1 2 2 2 2 2 wb 1
1 1 2 2 2 2 2 1 1
1 1 2 2 2 2 2 1 1
1 1 2 2 2 2 2 1 1
2 2 2 2 2 2 2 2 1
1 1 2 2 2 2 2 1 1
2 2 2 2 2 2 2 2 1
2 2 2 2 2 2 2 2 1
1 1 2 2 2 2 1c 2 21: PBM
CKS pa
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249HHV8 CELLULAR HOMOLOG GENE EXPRESSION IN KAPOSI’S SARCOMAexpression was observed in 3 of 4 AKS samples but in no
CKS samples (0 of 3). Only very weak expression of
vGCR was observed in TPA-untreated BCBL-1 cells,
while TPA treatment was associated with strong expres-
sion. Although vBCL2 expression was observed in all KS
samples, enhanced expression was observed in the 4
AKS samples with HIV-1 Tat expression. Transcription of
HIV-1 Tat was observed in 4 of 6 AKS samples. As
expected, no expression of HHV-8 genes or HIV-1 Tat
was observed in the normal control samples. Results of
constitutive cyclophilin gene expression indicate that
approximately equivalent amounts of RNA were sub-
jected to PCR amplification in all reactions.
DISCUSSION
Our results confirm the universal presence of vCYC
expression in KS (Cesarman et al., 1996; Davis et al.,
1997; Sarid et al., 1998). vCYC has been shown to be
resent in the majority of the spindle cells in late nodular
S lesions and thus has been proposed as an important
actor in KS pathogenesis by promoting cell-cycle pro-
ression (Chang et al., 1996; Davis et al., 1997; Godden-
ent et al., 1997).
In this study, vBCL2 expression was seen in all cases
f KS with an apparent enhancement of expression in
hose AKS samples with simultaneous HIV-1 Tat expres-
ion. vBCL2 may be important in KS pathogenesis by
nhibiting spindle cell apoptosis (Cheng et al., 1997; re-
iewed in Moore and Chang, 1998). The enhancement of
BCL2 expression in the presence of HIV-1 Tat suggests
hat vBCL2 may be particularly important in AKS patho-
enesis.
Our finding regarding the absence of detectable vIL-6
xpression in KS confirms similar findings of others and
uggests that vIL-6 does not play a significant role in KS
athogenesis (Cannon et al., 1999; reviewed in Moore
nd Chang, 1998). vIL-6 expression was observed in
PA-treated but not in untreated BCBL-1 cells in our
tudy and thus behaves as a class III gene and not as a
lass II gene as seen in BC-1 cells. This difference in
IL-6 gene expression in these two cell lines can likely
e explained by the presence of low-level spontaneous
ytic replication in BCBL-1 cells (Sarid et al., 1998).
Based on the lack of detectable vIRF1 expression by
orthern blot in a previous study of KS tissue, it was
uggested that vIRF1 does not play an important role in
S pathogenesis (Gao et al., 1997). However, using a
uch more sensitive RT-PCR method, we frequently de-
ected vIRF1 expression in both AKS and CKS samples,
ith enhanced expression seen in AKS samples with
IV-1 Tat expression. In BCBL-1 cells, vIRF1 exhibited a
lass I profile rather than the class II profile previously
escribed in BC-1 cells (Sarid et al., 1998). Our findings
uggest that vIRF1 may contribute to KS pathogenesis by
ntagonizing interferon-mediated antiviral immunity and
c
2nhibition of HHV-8-infected cell proliferation (Gao et al.,
997; Li et al.,1998; Zimring et al., 1998).
vMIP-I was expressed in all KS and PBMC samples
rom CKS patients while vMIP-II expression was seen in
o samples. It has been shown that vMIP-I and vMIP-II
nduce angiogenesis in vitro (Moore et al., 1996; Boshoff
t al., 1997). Therefore, our results suggest that vMIP-I,
ut not vMIP-II, may contribute to KS angiogenesis.
MIP-I exhibited a class I profile in both TPA-treated and
ntreated BCBL-1 cells, while vMIP-II exhibited a class III
rofile (i.e., was expressed only in TPA-treated cells).
No expression of vCBP was identified in KS in this
tudy. Therefore, vCBP is highly unlikely to play a role in
S pathogenesis. vCBP was expressed in TPA-treated
ut not in untreated BCBL-1 cells and thus behaves as a
lass III transcript as described in BC-1 cells (Sarid et al.,
998). HIV-1 Tat has been shown to induce HHV-8 repli-
ation in infected PBMC and BCBL-1 cells in vitro (Har-
ington et al., 1997). Extracellular HIV-1 Tat can be de-
ected in AKS tissue and the HIV-1 Tat receptor is highly
xpressed in KS spindle cells (Albini et al., 1996). Bais et
l. (1998) found that vGCR induces cellular transforma-
ion and tumorigenesis of endothelial cells in vitro and
nduces synthesis of vascular endothelial growth factor
VEGF), which stimulates growth of KS spindle cells and
as tumorigenic and angiogenic effects. vGCR expres-
ion has been previously identified in AKS (Cesarman et
l., 1996; Guo et al., 1997). In the present study, vGCR
xpression was not detected in CKS specimens, and
as seen only in those AKS specimens in which HIV-1
at expression was identified. Thus, HIV-1 Tat may in-
uce vGCR expression in AKS and indirectly contribute
o AKS pathogenesis through the tumorigenic and angio-
enic effects of vGCR. In addition to the profound effect
n vGCR expression, HIV-1 Tat expression in AKS is also
ssociated with increased expression of vBCL2 and
IRF1 (see Fig. 1 and Table 1).
In summary, the present results strongly suggest that
IV-1 Tat modulates HHV-8 gene expression in AKS and
hat in contrast to CKS, HHV-8 vGCR in particular may
ontribute to AKS pathogenesis.
MATERIALS AND METHODS
pecimen collection and storage
Fresh-frozen skin KS biopsies (6 AKS, 3 CKS) were
tored at 270°C and were subjected to RNA extraction
ithin 7 days. All samples were examined pathologically
nd confirmed as KS. Peripheral blood mononuclear cell
PBMC) samples from two of the CKS patients were also
ollected and immediately subjected to RNA extraction.
he HHV-8-positive lymphoid cell line BCBL-1 (NIH AIDS
esearch and Reference Reagent Program, Rockville,
D) were cultured for 48 h in RPMI 1640 with 10% fetalalf serum (Gibco-BRL, Grand Island, NY) with or without
0 ng/ml 12-O-tetradecanoylphorbol-13-acetate (TPA).
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250 YEN-MOORE ET AL.Normal tissue and PBMC controls consisted of skin and
peripheral blood of HIV-negative patients without KS,
cultured normal human epidermal keratinocytes (NHEK;
Clonetics, Walkersville, MD), cultured normal human mi-
crovascular endothelial cells (HMVEC; Clonetics), and
reagent controls.
RNA analysis
Total RNA was isolated from the KS specimens,
PBMC, BCBL-1 cells, and normal tissue controls utilizing
the TRI REAGENT (Molecular Research Center, Inc., Cin-
cinnati, OH). To exclude contaminating DNA, samples
were treated with DNase I (Gibco-BRL). Following RNA
extraction, the RNA was stored as an ethanol precipitate
at 270°C. Five micrograms of total RNA was reverse-
transcribed using random hexamers and Superscript II
RNase H2 Reverse Transcriptase (Gibco-BRL). Aliquots
f the RT mixtures were then amplified by PCR (30
ycles) with specific primers for the vCYC, vGCR, vMIP-I,
MIP-II, vBCL2, vIRF1, vIL-6, and vCBP genes of HHV-8
nd HIV-1 Tat (Bruggeman et al., 1994; Cesarman et al.,
996; see Table 2). Human cyclophilin (CP) mRNA was
mplified from all specimens as an internal reference
housekeeping) control to ensure intact mRNA. PCR re-
ctions were performed in a thermal cycler (PC-100; MJ
esearch Inc., Watertown, MT) using Easy Start preali-
uoted PCR master mix tubes (Molecular Bio-Products,
nc., San Diego, CA) and AmpliTaq DNA Polymerase
Perkin–Elmer, Roche Molecular Systems, Inc., Branch-
urg, NJ). Reaction mixtures were subjected to an initial
min denaturation at 94°C followed by 30 cycles of
enaturation (1 min at 94°C), annealing (45 s at 66°C,
xcept CP gene, which was 55°C), and extension (1 min
t 72°C). The same reactions were also performed with
NA that was not reverse-transcribed to exclude the
resence of DNA as the source of template for the PCR
roducts. Fractionation of the PCR mixtures was carried
TABLE 2
Nucleotide Positions of Primers and Oligonucleotide Probes
Sense
primer
Antisense
primer Probe
Genbank
number
16–40 130–111 78–101 U24276
187–212 666–641 454–474 U24275
1–25 269–245 114–190 U74585
1832–21809 21553–21577 21742–21719 U75698
1–25 516–492 222–246 U67773
5106–85087 84788–84807 84871–84895 U75698
1–25 612–588 181–205 U67774 or U73655
1142–1168 1382–1358 1275–1251 U75698
88–107 358–338 212–232 Y00052
5893–5914 6035–6013 5922–5945 Z11530ut on a 2% Seakem GTG agarose gel (FMC, Rockland,
E), after which fragments were blotted to a nylon mem-rane. Specificity of the PCR amplifications was con-
irmed by Southern blot analysis using the 32P-labeled
gene-specific oligonucleotide probes (Table 2). Oligonu-
cleotide labeling, hybridization, washing, and autora-
diography were carried out as previously described
(Rady et al., 1995).
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